ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 58575 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 58575; 2) Community: the network communities that were significantly associated with the response to NSC 58575; 3) Molecule: the relationships between components within communities and NSC 58575; 4) MDR: the compounds that were significantly associated with the NSC 58575.

NSC Compound Enrichment Correlation
NSC 731527 cyanoaminopyranopyridine derivatives 0.0339770934764509 -0.16415052
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0339770934764509 -0.37269456
NSC 677949 Quinoline-5,8-dione, 7-[(3-hydroxy-3-phenyl-2-propyl)amino]- 0.0339770934764511 0.042750205
NSC 683557 Camptothecin Derivative 0.0339770934764511 0.26774933
NSC 698688 Null 0.0339770934764511 0.057246274
NSC 732661 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]i soquinoline 0.0339770934764511 0.062602116
NSC 756738 DIGOXIN 0.0339770934764511 0.13741543
NSC 219734 1,8-Octanediamine, N,N'-di-9-acridinyl- (9CI) 0.0339770934764513 0.33687966
NSC 271674 Carboxyphthalatoplatinum 0.0339770934764513 0.47355181
NSC 30637 Null 0.0339770934764513 0.54507997
Total:99  Current:65    [First] [Prev] [Next] [Last]